TILT Holdings (TLLTF) Current Deferred Revenue (2021 - 2025)
TILT Holdings (TLLTF) reported Current Deferred Revenue of $1.4 million for Q2 2025, down 64.19% on a YoY basis from $4.0 million in Q2 2024, and down 17.34% quarter-over-quarter from $1.7 million in Q1 2025.
TILT Holdings (TLLTF) Current Deferred Revenue (2021 - 2025) Analysis & Trends
TILT Holdings has reported Current Deferred Revenue for 5 years, with the latest figure at $1.4 million in Q2 2025.
- For the quarter ending Q2 2025, Current Deferred Revenue fell 64.19% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2025 stood at $1.4 million (down 64.19% YoY), and the FY2024 full-year result was $3.1 million, down 48.33% from the prior year.
- Current Deferred Revenue for Q2 2025 stood at $1.4 million, down from $1.7 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $6.1 million in Q4 2023, with the low at $1.4 million in Q2 2025.
- Historically, Current Deferred Revenue has averaged $4.1 million across 5 years, with a median of $4.1 million in 2022.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue soared 43.84% — and 2025, when it plunged 64.19%.
- TILT Holdings' Current Deferred Revenue stood at $5.2 million in 2021, then gained by 11.26% to $5.8 million in 2022, then climbed by 5.61% to $6.1 million in 2023, then slumped by 48.33% to $3.1 million in 2024, then tumbled by 54.66% to $1.4 million in 2025.
- The last three Current Deferred Revenue figures came in at $1.4 million (Q2 2025), $1.7 million (Q1 2025), and $3.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.73 Mn |
| Jun 30, 2024 | 3.98 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 6.08 Mn |
| Sep 30, 2023 | 4.04 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 5.76 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 3.76 Mn |
| Dec 31, 2021 | 5.18 Mn |